Nadine Mallak

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “[18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab”.

[18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab

Neuro-Oncology Practice(2022)10.1093/nop/npac021

N/A

0DataRank · unranked

10 citations

Prakash Ambady, Jeanne Link, Kenneth A. Krohn, Ahmed M. Raslan, Nadine Mallak +4 more

Clinical Utility of [ 18 F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma

American Journal of Neuroradiology(2025)10.3174/ajnr.a9120

N/A

0DataRank · unranked

1 citations

Kellen Vo Vu, Rongwei Fu, Andrew Brandmaier, László Szidonya, Gagandeep Choudhary +41 more